Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.56 (
insulin-degrading enzyme
)
737
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently described the purification and characterization of an
insulin-degrading enzyme
(
IDE
) from Drosophila melanogaster that can cleave porcine insulin, is highly conserved through evolution and is developmentally regulated. We now report that the
IDE
is, in fact, an insulin EGF-binding protein (dp100) that we had isolated previously from Drosophila using an antihuman
EGF receptor
antiserum. This conclusion is based upon the following evidence. (a) dp100, identified by its ability to cross-link to labeled insulin, EGF, and transforming growth factor-alpha (TGF-alpha), and to be immunoprecipitated by anti-
EGF receptor
antisera, copurifies with the
IDE
activity. Thus, the purified
IDE
can be affinity labeled with either 125I-insulin, 125I-EGF, or 125I-TGF-alpha, and this labeling is specifically inhibited with unlabeled insulin, EGF, and the insulin B chain. (b) The antiserum to the human
EGF receptor
, which recognizes dp100, is able to specifically immunoprecipitate the insulin-degrading activity. (c) The purified
IDE
preparation contains a single protein of 110 kD which is recognized by both the anti-
EGF receptor
antiserum and anti-Drosophila
IDE
antiserum. (d) Polyclonal antiserum to the purified
IDE
, which specifically recognized only the 110-kD band in Drosophila Kc cells, immunoprecipitates dp100 cross-linked to 125I-TGF-alpha and dp100 cross-linked to 125I-insulin from the purified
IDE
preparation. (e) EGF, which competes with insulin for binding to dp100, also inhibits the degradation of insulin by the purified
IDE
. These results raise the possibility that a functional interaction between the insulin and EGF growth factor families can occur which is mediated by the
insulin-degrading enzyme
.
...
PMID:An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity. 249 23